Abstract.
Objective and design
Chronic glucocorticoid treatment is associated with pharmacological resistance. We investigated the auxiliary effects of fructose-1,6-bisphosphate (FBP) on dexamethasone (DEX)-related modulation of inflammation and T-cell proliferation.
Methods
Acute inflammation (pleurisy) was induced by injection of carrageenan into the pleural cavity of rats that were treated in vivo with DEX s. c. and FBP i. p. Peripheral blood mononuclear cells were isolated and T-cell sensitivity to FBP and DEX was evaluated in vitro.
Results
FBP and DEX reduced the exudate volume, protein concentration and neutrophils in the pleural cavity. However no synergistic effects were observed when these compounds were tested simultaneously. In contrast, both compounds dose-dependently and synergistically suppressed T-cell proliferation.
Conclusion
These data suggest that FBP may be beneficial as auxiliary drug for the treatment of patients with acquired glucocorticoid resistance.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received 7 November 2005; returned for revision 15 January 2006; accepted by I. Ahnfelt-Rønne 29 March 2006
Rights and permissions
About this article
Cite this article
Lopes, R.P., Lunardelli, A., Preissler, T. et al. The effects of fructose-1,6-bisphosphate and dexamethasone on acute inflammation and T-cell proliferation. Inflamm. res. 55, 354–358 (2006). https://doi.org/10.1007/s00011-006-6044-8
Issue Date:
DOI: https://doi.org/10.1007/s00011-006-6044-8